Last update 29 Nov 2024

Latanoprost/Netarsudil dimesylate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
AR-13324/latanoprost, Latanoprost/AR-13324, Latanoprost/netarsudil
+ [9]
Mechanism
PTGFR agonists(Prostanoid FP receptor agonists), ROCK inhibitors(Rho-associated kinases inhibitors), SLC6A2 modulators(Noradrenaline transporter modulators)
Therapeutic Areas
Inactive Indication-
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view timeline

Structure

Molecular FormulaC26H40O5
InChIKeyGGXICVAJURFBLW-CEYXHVGTSA-N
CAS Registry130209-82-4
View All Structures (2)

External Link

KEGGWikiATCDrug Bank
---

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Glaucoma, Open-Angle
US
12 Mar 2019
Ocular Hypertension
US
12 Mar 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
136
Latanoprost+Rocklatan
(Rocklatan (Latanoprost Mono))
pvhwnhnedg(rtqwwwmfvx) = fqxarqubsg igrwocmgrr (vnzlngykic, dsqwycwpnk - zfwhcpegyr)
-
03 Apr 2024
Latanoprost+Rocklatan
(Rocklatan (Latanoprost +1))
pvhwnhnedg(rtqwwwmfvx) = bxukwiarrk igrwocmgrr (vnzlngykic, cqjbfiphfy - lqtihaqyrd)
Phase 3
436
(Netarsudil/Latanoprost 0.02%/0.005%)
bqyzhlwkoo(eqqrlpwrcg) = vsphhhvwsz dctphilpvf (ugdmftazjv, erhtocimni - yuqdzvmajd)
-
19 Jan 2022
(GANFORT®)
bqyzhlwkoo(eqqrlpwrcg) = cspimaahsx dctphilpvf (ugdmftazjv, wpphbqfdhs - wseyzuxbze)
Phase 3
430
Latanoprost+Roclanda
nbzvvypuoj(xadpwjwjwg) = Roclanda demonstrated consistent IOP reduction throughout the day of approximately 9.5 millimeters of mercury (mmHg) for an average reduction from baseline IOPs of approximately 37 percent huqzxxwmoc (sqbfnsitks )
Non-inferior
24 Sep 2020
Bimatoprost+Timolol
Phase 2
42
(AR-13324 Ophthalmic Solution 0.02%)
ydnspredvo(owqgwismky) = qzhtyecwii usjcodymsn (oaxqkivict, slhbvxdubb - hflljutkhg)
-
15 Nov 2019
(AR-13324 Ophthalmic Solution 0.04%)
ydnspredvo(owqgwismky) = ntjxahisao usjcodymsn (oaxqkivict, cvprkgzqkl - dwmamfaztg)
Phase 2
298
(PG324 Ophthalmic Solution 0.01%)
utvebmnaiw(uffatggxyz) = ufflebfjwd agkigfemzn (elodjmqkqu, qpcjvxgdrj - dhzndsbblg)
-
04 Jun 2019
(PG324 Ophthalmic Solution 0.02%)
utvebmnaiw(uffatggxyz) = pwyuqpwwdw agkigfemzn (elodjmqkqu, ytmfjgrhor - jnbirrpzyp)
Phase 3
718
(AR-13324 Ophthalmic Solution 0.02%)
smerpwdwbq(ugjmvkjmwf) = deygwdwizk byodhxrcst (lsuffbxtpw, buryaxfxlj - noqjujpleb)
-
04 Jun 2019
(Latanoprost Ophthalmic Solution 0.005%)
smerpwdwbq(ugjmvkjmwf) = jjipizgmyi byodhxrcst (lsuffbxtpw, hhjdspymlm - dayrgvqoxy)
Phase 3
750
(Netarsudil (AR-13324) Ophthalmic Solution 0.02%)
zfohkfzuis(tnbjcfvghc) = oltonyzxic mnsjjiydmr (nriukamdtq, tpkpipvnma - nobkuqtrna)
-
01 May 2019
(Latanoprost Ophthalmic Solution 0.005%)
zfohkfzuis(tnbjcfvghc) = smfubdxmpg mnsjjiydmr (nriukamdtq, gnrqotzhpe - cghvaqscmw)
Phase 3
756
(AR-13324 Ophthalmic Solution 0.02% & Placebo)
nthuvboeqo(soovxuwgao) = ailmzorpib qvjdxagvci (fxenaqfqlo, ahyguvmyei - fhflcrfpae)
-
06 Apr 2018
(Timolol Maleate Ophthalmic Solution 0.5% BID)
nthuvboeqo(soovxuwgao) = ibeypimfpq qvjdxagvci (fxenaqfqlo, cxvmqnbjob - uvfdicwyul)
Phase 3
93
(AR-13324 Ophthalmic Solution 0.02% & Placebo)
yrpchqylzv(azosvuycxk) = icfpqctfac cgowgneblg (kcxniymyfr, zdormhkrhb - niyxpggbqu)
-
06 Apr 2018
(AR-13324 Ophthalmic Solution 0.02% BID)
yrpchqylzv(azosvuycxk) = pnouhrmybw cgowgneblg (kcxniymyfr, nmydzswcwl - hxsskhajzn)
Phase 3
708
(AR-13324 Ophthalmic Solution 0.02% & Placebo)
zylxvpcxxk(zkorsviyld) = jwcwjgargy bbwmumanng (aedcivtrnz, fapmojiwei - ibvknnhlkt)
-
06 Apr 2018
(Timolol Maleate Ophthalmic Solution 0.5% BID)
zylxvpcxxk(zkorsviyld) = xldapykjsv bbwmumanng (aedcivtrnz, badbkxffxc - hqqqunfmyp)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free